About AGEN

Agenus is an immunology company engaged in the discovery and development of novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases. Using its proprietary platforms Retrocyte Display and SECANT, the Company is discovering and developing novel antibodies to target GITR, OX40, CTLA-4, LAG-3, TIM-3, PD-1, CEACAM1 and other undisclosed checkpoints in partnered and internal programs. Agenus heat shock protein vaccine, Prophage, has successfully completed Phase 2 studies in newly diagnosed glioblastoma multiforme. The Companys QS-21 Stimulon adjuvant is partnered with GlaxoSmithKline and Janssen Sciences Ireland UC.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Biological Product (except Diagnostic) Manufacturing

AGEN is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
URTY ProShares UltraPro Russell2000 97.7 M 9.76575E+07 2,016 2016 0.0% 3.38851E-05 11 K 10516
UWM ProShares Ultra Russell2000 167.6 M 1.67596E+08 2,016 2016 0.01% 5.01884E-05 18 K 18243
PXSG Invesco Russell 2000 Pure Growth ETF 85.9 M 8.59E+07 301 301 0.05% 0.00048 43 K 43448
VHT Vanguard Health Care ETF 9.4 B 9.400001E+09 361 361 0.01% 7E-05 687 K 686556
VTWG Vanguard Russell 2000 Growth ETF 286.3 M 2.863E+08 1,245 1245 0.03% 0.00025 73 K 72831
VTWO Vanguard Russell 2000 ETF 1.6 B 1.6E+09 2,013 2013 0.01% 0.00013 205 K 205293
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.3 B 1.83396E+10 3,566 3566 0.0% 0 135 K 135340
IWC iShares Microcap ETF 881.6 M 8.81617E+08 1,452 1452 0.07% 0.0007 626 K 625642
IWM iShares Russell 2000 ETF 43.1 B 4.31393E+10 2,005 2005 0.01% 0.0001 5.1 M 5122430
IWO iShares Russell 2000 Growth ETF 8.9 B 8.92227E+09 1,238 1238 0.02% 0.0002 2.2 M 2178440
IWV iShares Russell 3000 ETF 9.5 B 9.51742E+09 2,930 2930 0.0% 0 79 K 79087
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 354 354 0.01% 7.47805E-05 120 K 120473

Wait, Before You Leave...